换一批Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure.
第一作者：
Sajir G,Mohamedbhai
第一单位：
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
作者：
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);女(雌)性(Female);移植物排斥(Graft Rejection);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病(Leukemia);淋巴细胞去除术(Lymphocyte Depletion);淋巴细胞输注(Lymphocyte Transfusion);淋巴瘤(Lymphoma);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies);T淋巴细胞(T-Lymphocytes);移植嵌合体(Transplantation Chimera);移植, 同种(Transplantation, Homologous);青年人(Young Adult)
DOI
10.1111/j.1365-2141.2011.08944.x
PMID
22171699
发布时间
2017-11-16
基金项目
Cancer Research UK/United Kingdom
Department of Health/United Kingdom
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
